Éric Baudin

1990–2025 年に発表

別表記
Eric Baudin
189
論文数
34,019
被引用数
105
h 指数
186
i10 指数

被引用数

Éric Baudin の年別被引用数1984 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 5 件1996 年: 被引用 3 件1997 年: 被引用 5 件1998 年: 被引用 10 件1999 年: 被引用 15 件2000 年: 被引用 26 件2001 年: 被引用 49 件2002 年: 被引用 47 件2003 年: 被引用 38 件2004 年: 被引用 75 件2005 年: 被引用 61 件2006 年: 被引用 101 件2007 年: 被引用 106 件2008 年: 被引用 112 件2009 年: 被引用 186 件2010 年: 被引用 179 件2011 年: 被引用 182 件2012 年: 被引用 270 件2013 年: 被引用 277 件2014 年: 被引用 264 件2015 年: 被引用 290 件2016 年: 被引用 221 件2017 年: 被引用 287 件2018 年: 被引用 292 件2019 年: 被引用 1,034 件2020 年: 被引用 1,111 件2021 年: 被引用 980 件2022 年: 被引用 717 件2023 年: 被引用 547 件2024 年: 被引用 913 件2025 年: 被引用 393 件2026 年: 被引用 7 件1985〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,000 件、この内訳の 21%イタリア: 引用元論文 971 件、この内訳の 10.2%フランス: 引用元論文 850 件、この内訳の 8.9%ドイツ: 引用元論文 714 件、この内訳の 7.5%イギリス: 引用元論文 534 件、この内訳の 5.6%中国: 引用元論文 514 件、この内訳の 5.4%オランダ: 引用元論文 411 件、この内訳の 4.3%スイス: 引用元論文 292 件、この内訳の 3.1%カナダ: 引用元論文 281 件、この内訳の 3%スペイン: 引用元論文 264 件、この内訳の 2.8%オーストラリア: 引用元論文 242 件、この内訳の 2.6%スウェーデン: 引用元論文 228 件、この内訳の 2.4%
0%21%その他 23.2%

分野

  • Medicine88.8%
  • Biochemistry, Genetics and Molecular Biology9.4%
  • Computer Science0.2%
  • Immunology and Microbiology0.2%
  • Neuroscience0.2%
  • Nursing0.2%
  • その他1%

トピック

  • Neuroendocrine Tumor Research Advances10.7%
  • Thyroid Cancer Diagnosis and Treatment9.8%
  • Adrenal and Paraganglionic Tumors7.3%
  • Lung Cancer Research Studies6.7%
  • Neuroblastoma Research and Treatments5%
  • Cancer, Hypoxia, and Metabolism4.3%
  • その他56.2%

共著者

全論文

検索で開く
  1. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Sylvia, Richard J. Auchus, J. Todd Auman, Robert Baertsch, Miruna Balasundaram, Saianand Balu, Detlef K. Bartsch, Éric Baudin, Thomas Bauer, Allison Beaver, Christopher C. Benz, Rameen Beroukhim, Felix Beuschlein, Tom Bodenheimer, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Rebecca Carlsen, Suzie Carter, Clarissa A. Cassol, Andrew D. Cherniack, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Leslie Cope, Daniel Crain, Erin Curley, Ludmila Danilova, Aguirre A. de Cubas, Ronald R. de Krijger, John A. Demchok, Timo Deutschbein, Noreen Dhalla, David Dimmock, Winand N.M. Dinjens, Tobias Else, Charis Eng, Jennifer Eschbacher, Martin Faßnacht, Ina Felau, Michael D. Feldman, Martin L. Ferguson, Ian T. Fiddes, Lauren Fishbein, Scott Frazer, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Jennifer L. Geurts, Hans K. Ghayee, Anne‐Paule Gimenez‐Roqueplo, Thomas J. Giordano, Mary J. Goldman, Kiley Graim, Manaswi Gupta, David Haan, Stefanie Hahner, Constanze Hantel, David Haussler, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Robert A. Holt, Alan P. Hoyle, Mei Huang ほか 132 名 - Cancer Cell 2017 被引用: 783

  2. Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 1,550

  3. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    著者: , , , , , , , , , - European Journal of Endocrinology 2018 被引用: 941

  4. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , , , , - Annals of Oncology 2020 被引用: 420

  5. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 139

  6. Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanneke Wilmink, Monica Sender, Maureen Edgerly, W. Kenn, Tito Fojo, Hans‐Helge Müller, Britt Skogseid - New England Journal of Medicine 2012 被引用: 864

  7. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James C. Yao - European Journal of Cancer 2021 被引用: 242

  8. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 被引用: 699

  9. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Endocrinology 2021 被引用: 163

  10. Anaplastic Thyroid Carcinoma: An Update

    著者: , , , , , , , , , , , , - Cancers 2022 被引用: 151

  11. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    著者: , , , , , , , , , , , , - The Lancet 2011 被引用: 1,052

  12. Integrated genomic characterization of adrenocortical carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felix Beuschlein, Rossella Libé, Aurélien de Reyniès, Jérôme Bertherat - Nature Genetics 2014 被引用: 733

  13. Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    著者: , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 256

  14. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabelle Borget, Éric Baudin, European Network for the Study of Adrenal Tumors (ENS@T) - The Journal of Clinical Endocrinology & Metabolism 2019 被引用: 180

  15. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

    著者: , , , , , , , , , , , , , , , , , , , - Neuroendocrinology 2017 被引用: 497

  16. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies

    著者: , , , , , , , , , , , , , , , , , , , - Cancer 2022 被引用: 49

  17. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 137

  18. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

    著者: , , , , , , , , , , , , , - Neuroendocrinology 2016 被引用: 606

  19. Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 被引用: 335

  20. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frédéric Castinetti, Jérôme Bertherat, Rossella Libé, Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Marcus Quinkler, Christian J. Strasburger, Katrin Zopf, Martín Reincke, Matthias Kroiß, Hanna Remde, Michaela Haaf, Carmina Teresa Fuß, Ulrich Dischinger, Graeme Eisenhofer, Christina Pamporaki, Anouk van Berkel - The Lancet 2024 被引用: 66

  21. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

    著者: , , , , , , , , - Neuroendocrinology 2012 被引用: 870

  22. MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion

    著者: , , , , , - European Journal of Endocrinology 2020 被引用: 226

  23. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

    著者: , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2014 被引用: 204

  24. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 333